Professor Anton Pottegrd , from the University of Southern Denmark, and coauthors, analyzed databased from six countries, comparing patients with type 2 diabetes between 2007 and 2023 for the risk of thyroid cancer among GLP1-RA users compared with dipeptidyl peptidase-4 inhibitors (DPP-4is)
close INR monitoring is essential
Journal of Physiology (Paris)
Recalls & Warnings August 20, 2020 Goldenseal Recalled Due to Microbial Contamination, One Death Reported On August 17, 2020, Maison Terre issued a recall of all lots of organic Goldenseal Root Powder because recent testing found it has the potential to be contaminated with various microorganisms including Enterobacter cloacae, Cronobacter sakazakii, Cronobacter dublinensis, and others
It underwent clinical trials for the treatment of obesity but did not receive regulatory approval for commercial use due to concerns about its safety profile
After the FDA declared shortages of the drugs over, for tirzepatide in December and semaglutide in February, it told pharmacies and companies they had a few months before they had to stop making copies of the name-brand medications